We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.

Journal Scan / Research · July 17, 2021

Association Between Achieved ω-3 Fatty Acid Levels and MACE in Patients at High Cardiovascular Risk

JAMA Cardiology


Additional Info

Disclosure statements are available on the authors' profiles:

JAMA Cardiology
Association Between Achieved ω-3 Fatty Acid Levels and Major Adverse Cardiovascular Outcomes in Patients With High Cardiovascular Risk: A Secondary Analysis of the STRENGTH Trial
JAMA Cardiol 2021 May 16;[EPub Ahead of Print], SE Nissen, AM Lincoff, K Wolski, CM Ballantyne, JJP Kastelein, PM Ridker, KK Ray, DK McGuire, D Mozaffarian, W Koenig, MH Davidson, M Garcia, BG Katona, A Himmelmann, LE Loss, M Poole, V Menon, SJ Nicholls

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading